Sphingosine-1-phosphate as signaling molecule in the skin;Sphingosin-1-phosphat als signalmolekül der haut: Bedeutungbeim atopischen ekzem

Allergo Journal

Volumn 23, Issue 2, 2014, Pages 18-23

  Japtok, Lukasz ^a   Bäumer, Wolfgang ^b   Kleuser, Burkhard ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOSINE 1 PHOSPHATE;

NOTE; SKIN;

EID: 84905259895     PISSN: 09418849     EISSN: 21956405     Source Type: Journal    
DOI: 10.1007/s15007-014-0516-x     Document Type: Note

References (23)

1. Hamanaka S, Hara M, Nishio H, Otsuka F, Suzuki A, Uchida Y. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002; 119: 416-23 (Pubitemid 35001952)
2. Jensen JM, Fölster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423-31 (Pubitemid 38757224)
3. Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, et al. Characterization of overall ceramide species in human stratum corneum. J Lipid Res 2008; 49: 1466-76
4. Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006; 580: 5456-66 (Pubitemid 44465907)
5. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-6
6. Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, Rothermel U et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 2012; 21: 586-608
7. Lee MJ, Van Brooklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R,et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998; 279: 1552-5 (Pubitemid 28217081)
8. Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 2002; 277: 25843-6
9. Bagdanoff JT, Donoviel MS, Nouraldeen A, Carlsen M, Jessop TC, Tarver J et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4((1R,2S,3R)-1,2,3,4- tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J Med Chem 2010; 53: 8650-62
10. Ito K, Anada Y, Tani M, Ikeda M, Sano T, Kihara A, Igarashi Y. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun 2007; 357: 212-7 (Pubitemid 46574517)
11. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008; 102: 669-76 (Pubitemid 351457860)
12. Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 2011; 11(6): 403-15
13. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277: 21453-7 (Pubitemid 34952287)
14. Manggau M, Kim DS, Ruwisch L, Vogler R, Korting HC, Schäfer-Korting M, Kleuser B. 1Alpha,25-dihydroxy vitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 2001; 117(5): 1241-9 (Pubitemid 34205924)
15. Lichte K, Rossi R, Danneberg K, ter Braak M, Kürschner U, Jakobs KH et al. Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol 2008; 128: 1487-98 (Pubitemid 351693197)
16. Schüppel M, Kürschner U, Kleuser U, Schäfer-Korting M, Kleuser B. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J Invest Dermatol 2008; 128: 1747-56 (Pubitemid 351847385)
17. Japtok L, Schaper K, Bäumer W, Radeke HH, Jeong SK, Kleuser B. Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P(2) receptor subtype. PLoS One 2012; 7: e49427
18. Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol 2005; 174: 2778-86 (Pubitemid 40279694)
19. 1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. Mol Immunol 2011; 48: 1139-48
20. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012; 122: 440-7
21. Seo EY, Park GT, Lee KM, Kim JA, Lee JH, Yang JM. Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol 2006; 126: 1187-9
22. Bäumer W, Rossbach K, Mischke R, Reines I, Langbein-Detsch I, Lüth A, Kleuser B. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol 2011; 131: 266-8
23. Reines I, Kietzmann M, Mischke R, Tschernig T, Lüth A, Kleuser B, Bäumer W. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol 2009; 129: 1954-62